drugset / Trial / NCT04500899

Use of Phenylephrine for Assessment of Mitral Regurgitation Severity

NCT04500899

NaSingle-groupOpen-labelDiagnostic

Summary

The study proposes to develop a phenylephrine protocol to be used during transesophageal echocardiography, whereby intravenous phenylephrine would be used to increase afterload with the intent to mimic the awake hemodynamic profile and variation that occurs with normal physical activity. The expectation is to see changes in severity of Mitral Regurgitation (MR) grade with increasing afterload, which in turn can provide more accurate quantification of MR severity to assist in clinical decision making.

Timeline

Start
2020-12-01
Primary completion
2026-06
Completion
2026-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 50 ug Intravenous